Financials
- Market Capitalization 1.8 B
- Employee 1 605
- Founded 2000
- CEO Asaf Danziger
- Website www.novocure.com
- Headquarter N/A
- FIGI N/A
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1966 | AXGN Axogen, Inc. - Common Stock | 38.77 USD | -1.82% | -11.85% | -10.87% | +112.55% | 2.06 B USD | ||
| 1978 | BFLY Butterfly Network, Inc. Class A Common Stock | 7.76 USD | -4.08% | +6.01% | +37.10% | +335.96% | 2.03 B USD | ||
| 2079 | UFPT UFP Technologies, Inc. - Common Stock | 230.11 USD | -3.01% | -11.96% | -5.10% | +13.24% | 1.78 B USD | ||
| 2212 | IART Integra LifeSciences Holdings Corporation - Common Stock | 18.40 USD | -0.97% | +6.98% | +1.71% | +14.14% | 1.43 B USD |
Frequently asked questions about NovoCure Limited - Ordinary Shares
What is the NovoCure Limited - Ordinary Shares stock price today?
The current price of NovoCure Limited - Ordinary Shares (NVCR) is 15.55. Over the past 24 hours, the stock has changed by -3.36%. Follow the NVCR chart for real-time price dynamics.
What is the stock ticker of NovoCure Limited - Ordinary Shares?
NovoCure Limited - Ordinary Shares trades under the ticker NVCR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NovoCure Limited - Ordinary Shares stock going up?
NVCR has changed by -10.01% over the last week, -15.12% over the last month, and +13.09% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was NovoCure Limited - Ordinary Shares net income for the last quarter?
NovoCure Limited - Ordinary Shares reported net income of -71.14 M for the last quarter. The previous quarter showed -24.5 M, which means net income changed by -190.37%.
How many employees does NovoCure Limited - Ordinary Shares have?
As of the latest available data, NovoCure Limited - Ordinary Shares has 1 605 employees. Workforce size can provide additional context about the company's scale and operations.
What is NovoCure Limited - Ordinary Shares EBITDA?
NovoCure Limited - Ordinary Shares EBITDA is -70.04 M, and its EBITDA margin is -40.24%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NovoCure Limited - Ordinary Shares stock?
You can buy NovoCure Limited - Ordinary Shares (NVCR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NovoCure Limited - Ordinary Shares stock?
Investing in NovoCure Limited - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NVCR chart and related analysis on metatrader.com as part of your research.